DJIA 17,719.92 -78.57 -0.44%
NASDAQ 5,108.67 -18.86 -0.37%
S&P 500 2,080.41 -9.70 -0.46%
market minute promo

MannKind Corp (NASDAQ: MNKD)

2.00 -0.08 (-3.85%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MNKD $2.00 -3.85%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.07
Previous Close $2.08
Daily Range $2.00 - $2.11
52-Week Range $1.76 - $7.88
Market Cap $819.0M
P/E Ratio -6.50
Dividend (Yield) $0.00 (0.0%)
Volume 5,796,046
Average Daily Volume 8,355,687
Current FY EPS -$0.28




Drug Makers

MannKind Corp (MNKD) Description

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer. Website:

News & Commentary

3 Earnings Reports That Surprised Us This Quarter

Visa, MannKind, and WOOF top the list of surprises for these Motley Fool contributors.

MannKind: Weekly Data Updates- 11-20-15 Data

NASDAQ Companies With Largest Short Interest

MannKind: Weekly Data Updates- 11-13-15 Data

MannKind (MNKD) Stock Gains After CEO Resigns

MannKind Elder Abuse Is Replacing Inept CEO With Founder

Benzinga's Top #PreMarket Losers

MannKind's Desperation Move Comes Up Short -- Now What?

MannKind's stock offering in Israel misses the mark, leaving the company with few viable options left to raise capital.

Why MannKind's Listing in Israel Might Not Matter

A listing in Israel may provide some cash, but it's unlikely to be enough unless sales of Afrezza ramp.

MannKind (MNKD) Shows Strength: Stock Moves Up 18.9%

See More MNKD News...

MNKD's Top Competitors

MNKD $2.00 (-3.85%)
Current stock: MNKD
AMGN $161.10 (-1.48%)
Current stock: AMGN
GILD $105.96 (-1.89%)
Current stock: GILD
BIIB $286.86 (-2.17%)
Current stock: BIIB